{"id":369680,"date":"2026-03-05T19:37:16","date_gmt":"2026-03-05T19:37:16","guid":{"rendered":"https:\/\/www.europesays.com\/ie\/369680\/"},"modified":"2026-03-05T19:37:16","modified_gmt":"2026-03-05T19:37:16","slug":"gnosis-by-lesaffre-champions-womens-health-supplements-at-expo-west-2026","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/ie\/369680\/","title":{"rendered":"Gnosis by Lesaffre champions women\u2019s health supplements at Expo West 2026"},"content":{"rendered":"

Women\u2019s health is taking center stage at the ongoing Natural Products Expo West 2026 trade show. Gnosis by Lesaffre<\/a> is showcasing women\u2019s wellness ingredients that support prenatal health, digestion, and bone density, as well as heart, vaginal, and brain health.\u00a0<\/p>\n

On the showroom floor in Anaheim, California, US, Nutrition Insight<\/strong> catches up with Alina Slotnik, the company\u2019s marketing director for the Americas, to discuss opportunities to address women\u2019s health needs and consumer demands.\u00a0<\/p>\n

\u201cWomen\u2019s wellness is moving beyond prenatal and menopause silos toward a continuous, lifecycle-driven approach to health. Women today are taking greater ownership of their well-being, prioritizing proactive self-care and everyday health needs that extend well beyond hormonal milestones.\u201d<\/p>\n

\"arrow\"<\/a><\/p>\n

Slotnik says this shift is reflected in supplement use, with a majority of women worldwide taking supplements to stay healthy. \u201cIncreasingly, women\u2019s top concerns include weight management, stress, digestive, and metabolic health, often ranking ahead of hormone balance \u2014 underscoring demand for more holistic solutions.\u201d<\/p>\n

She notes that the nutrition industry is responding with innovations, signaling momentum for these products. For example, Innova Market Insights data indicates a 6% annual growth in supplement launches with women\u2019s health positionings<\/a> between October 2022 and September 2025. Nearly half of these were women\u2019s specialty products.<\/p>\n

\u201cAt Gnosis by Lesaffre, we define women\u2019s wellness as foundational support that adapts across life stages, grounded in science-backed ingredients that support core systems such as bone, cardiovascular, vaginal, digestive, and microbiome health,\u201d details Slotnik.<\/p>\n

\"AlinaAlina Slotnik, marketing director for the Americas, says women increasingly want multifunctional solutions, with multivitamins remaining the most popular format.\u201cBy focusing on clinically validated, lifecycle-relevant solutions, we aim to move beyond stage-specific narratives and empower women to thrive at every stage of life.\u201d<\/p>\n

Multifunctional solutions<\/p>\n

According to Slotnik, multi-benefit ingredients that address root biological pathways and long-term, systems-level health instead of isolated symptoms are defining the evolving landscape of women\u2019s health.<\/p>\n

\u201cWe\u2019re seeing clear momentum toward dual-benefit ingredients that reflect the interconnected nature of women\u2019s health. Women increasingly want efficient, multifunctional solutions rather than single-issue products, especially as they balance multiple health priorities.\u201d<\/p>\n

She highlights that this demand is reflected in broader innovation trends, as multivitamins remain the most popular format among women and new products increasingly combine complementary claims.<\/p>\n

\u201cBone and cardiovascular health are a strong example: both are top concerns for women and are biologically linked, particularly as estrogen declines, making separate solutions less relevant.\u201d<\/p>\n

For example, the company\u2019s MenaQ7 vitamin K2 solution also responds to the shift, as it supports bone density and arterial flexibility through a single clinically validated mechanism.<\/p>\n

Gnosis by Lesaffre\u2019s clinical evidence confirms cardiovascular benefits for this ingredient, as it helps the body utilize calcium and inhibit calcification. Slotnik notes that the company\u2019s research partners are exploring a connection to brain health, with seven trials underway. Based on identified associations, the team can explore underserved market segments.<\/p>\n

She also points to Gnosis by Lesaffre\u2019s Adonat Premium SAMe<\/a> (S-adenosyl-L-methionine) as exemplifying a shift to ingredients that work upstream, addressing shared biological roots and delivering clinically validated benefits across multiple health systems.<\/p>\n

\"PregnantAs Quatrefolic contains the bioactive form of folate, it bypasses an enzyme-dependent conversion of folic acid into 5-MTHF.\u201cAs a key methyl donor in one-carbon metabolism, SAMe supports more than 100 biochemical reactions. By targeting foundational pathways, SAMe delivers benefits across mood and cognitive health, cardiovascular support, joint and bone health, and menopausal comfort \u2014 without requiring multiple single-ingredient products.\u201d<\/p>\n

Bioactive folate<\/p>\n

Slotnik urges brands to rethink how folate is formulated and dosed, as women\u2019s health increasingly prioritizes personalization and bioavailability.<\/p>\n

\u201cThis is especially relevant as B vitamins are the fastest-growing active ingredient subcategory in women\u2019s health supplements, with folate among the most widely used and rapidly expanding.\u201d<\/p>\n

One of Gnosis by Lesaffre\u2019s featured solutions at Expo West 2026 is Quatrefolic. Slotnik notes that this stabilized bioactive folate form<\/a> \u2014 5-methyltetrahydrofolate or 5-MTHF \u2014 delivers consistent bioavailability across genetic profiles.<\/p>\n

Where folic acid has been the standard form of vitamin B9, she explains that 40% of the population cannot efficiently convert it into 5-MTHF, which can limit efficacy and contribute to elevated homocysteine levels linked to fertility, cardiovascular, and pregnancy-related concerns.<\/p>\n

Quatrefolic bypasses this enzyme-dependent conversion. \u201cThis makes it a more inclusive and reliable option for women at every life stage, as well as for brands seeking consistent performance globally.\u201d<\/p>\n

\u201cUltimately, rethinking folate means moving beyond legacy ingredients toward active forms that support foundational processes like DNA synthesis and methylation throughout a woman\u2019s lifecycle,\u201d underscores Slotnik. \u201cBy adopting bioactive folate solutions like Quatrefolic, brands can better align with modern expectations for efficacy, personalization, and transparency.\u201d<\/p>\n

Innovating for the vaginal microbiome<\/p>\n

Slotnik highlights vaginal health as another key women\u2019s health area. She says a growing awareness of the vaginal microbiome is reshaping women\u2019s probiotic innovation<\/a>, shifting from a generalized gut health focus to targeted, site-specific solutions that address real-world intimate health concerns.<\/p>\n

\u201cThis shift is reflected in market data: in 2024, more than half of women\u2019s health supplements containing probiotics targeted vaginal health, with strong growth in products addressing vaginal and urinary tract support.\u201d<\/p>\n

\"WomanAccording to Slotnik, more than half of women\u2019s health supplements containing probiotics targeted vaginal health in 2024.She notes that this momentum is driven by a deeper scientific understanding that the vaginal microbiome is distinct, dynamic, and highly sensitive to hormones, life stage, and external stressors.<\/p>\n

\u201cDisruptions to this ecosystem can allow opportunistic organisms, such as Candida albicans, to overgrow, leading to vulvovaginal candidiasis, a condition affecting roughly 75% of women at least once,\u201d explains Slotnik.\u00a0<\/p>\n

\u201cAs a result, innovation is moving away from broad-spectrum probiotics toward targeted solutions that actively address specific microbial imbalances, rather than simply adding bacteria.\u201d<\/p>\n

For example, Gnosis by Lesaffre\u2019s Quatreflora, a specialized probiotic yeast, has been clinically shown to benefit women with yeast infections caused by C. albicans, offering benefits over probiotic supplements for mitigating C. albicans overgrowth.<\/p>\n

Meanwhile, Slotnik says that women are becoming more \u201cmicrobiome-literate\u201d and increasingly view intimate health as part of a whole-body microbial system rather than an isolated issue. \u201cThis has elevated demand for clinically validated, mechanism-driven probiotic approaches designed to support microbial balance across interconnected systems.\u201d<\/p>\n

Digestive GLP-1 support<\/p>\n

Digestive support is becoming a core companion strategy for women using GLP-1 medications<\/a>, says Slotnik. She notes that women are both more likely to use GLP-1s and more biologically predisposed to digestive disorders, with conditions like irritable bowel syndrome (IBS) occurring two to six times more often than in men.<\/p>\n

\u201cGLP-1 therapies slow gastric emptying and alter gut motility, making nausea, bloating, constipation, diarrhea, and abdominal pain common reasons for discontinuation. For women already managing IBS-like symptoms, digestive support<\/a> plays a vital role in maintaining\u00a0comfort and adherence.\u201d<\/p>\n

Gnosis by Lesaffre\u2019s ibSium exemplifies an ingredient gaining traction in this space, according to Slotnik. \u201cSupported by multiple clinical trials and a meta-analysis, ibSium has demonstrated significant reductions in abdominal pain and bowel irregularity, with\u202f77% of users reporting improvement within 15 days\u202fand a meaningful subset experiencing relief within just five days.\u201d<\/p>\n

She says that this type of evidence-backed digestive support is crucial for women navigating GLP-1 therapy alongside IBS-like symptoms.\u00a0<\/p>\n

\u201cAs GLP-1 use continues to rise, brands that proactively integrate digestive comfort into women\u2019s health and weight-management platforms will be best positioned to meet evolving consumer needs.\u201d<\/p>\n","protected":false},"excerpt":{"rendered":"Women\u2019s health is taking center stage at the ongoing Natural Products Expo West 2026 trade show. Gnosis by…\n","protected":false},"author":2,"featured_media":369681,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[78],"tags":[18,171117,31184,104899,135,19,17,12000],"class_list":["post-369680","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health","tag-eire","tag-expo-west-2026","tag-folate","tag-gnosis-by-lesaffre","tag-health","tag-ie","tag-ireland","tag-womens-health"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@ie\/116178258805492931","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/369680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/comments?post=369680"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/posts\/369680\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media\/369681"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/media?parent=369680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/categories?post=369680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/ie\/wp-json\/wp\/v2\/tags?post=369680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}